Medically Integrated Dispensing Pharmacy: ASCO-NCODA (Network for Collaborative Oncology Development & Advancement) Standards Update
These revised and expanded ASCO-Network for Collaborative Oncology Development & Advancement standards further enhance existing guidance to practices and outpatient clinics engaging in or planning to initiate MIP. The goal is to improve clinical outcomes and patient satisfaction through adherence to rigorous standards in oral anticancer medication management, patient safety, and care coordination.Additional information is available at www.asco.org/standards.
Authors
- Adrienne D. Cox (ORCID: https://orcid.org/0000-0002-4901-2454)
- Gurjyot K. Doshi
- Melissa S. Dillmon
- Luis E. Raez (ORCID: https://orcid.org/0000-0003-2669-5771)
- Elizabeth A. Bell (ORCID: https://orcid.org/0000-0003-3952-7929)
- Scott Freeswick
- Xylina T. Gregg (ORCID: https://orcid.org/0009-0005-6832-7901)
- Neal Dave
- Stacey McCullough
- Eileen Peng (ORCID: https://orcid.org/0000-0002-8590-4943)
- Michael J. Reff
- Stuart Genschaw
- Bill Wimbiscus
- Kashyap Patel (ORCID: https://orcid.org/0000-0002-4188-1794)
- Elizabeth V. Bettencourt (ORCID: https://orcid.org/0009-0001-3843-0060)
Institutions
- Cazenovia College (US)
- Sutter Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- Sutter Medical Center (US)
- Harbin Clinic (US)
- Texas Oncology (US)
- Utah Cancer Specialists (US)
- CancerCare (US)
- Florida Cancer Specialists & Research Institute (US)
- Cancer Care of Western North Carolina (US)
- Hematology Oncology Consultants (US)
- Florida Atlantic University (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1200/op-25-00279
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00